Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia

We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Pede, Chiara, Congedi, Sabrina, Rossin, Sara, Divisic, Antuan, De Gregorio, Alesandra, Agosto, Caterina, Catalano, Igor, Mazza, Alessandro, Sartori, Leonardo, Masiero, Stefano, Benini, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055947/
https://www.ncbi.nlm.nih.gov/pubmed/27747122
http://dx.doi.org/10.1155/2016/2329483
Descripción
Sumario:We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.

Ejemplares similares